Kalaris Therapeutics Inc (KLRS)

Mar 04, 2026

KLRS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 04, 2026

Mar 03, 2026

Kalaris Therapeutics Inc expected to post a loss of 53 cents a shareEarnings Preview - TradingView

Mar 03, 2026

Mar 03, 2026

KLRS Should I Buy - Intellectia AI

Mar 03, 2026

Feb 27, 2026

Published on: 2026-02-28 06:52:09 - baoquankhu1.vn

Feb 27, 2026

Feb 22, 2026

ETFs Investing in Kalaris Therapeutics, Inc. Stocks - TradingView

Feb 22, 2026

Feb 21, 2026

Wall Street Zen Upgrades Kalaris Therapeutics (NASDAQ:KLRS) to Hold - MarketBeat

Feb 21, 2026

Feb 21, 2026

RTW INVESTMENTS, LP Acquires 1,300,000 Shares in Kalaris Therape - GuruFocus

Feb 21, 2026

Feb 20, 2026

RTW INVESTMENTS, LP Acquires 1,300,000 Shares in Kalaris Therapeutics Inc - GuruFocus

Feb 20, 2026

Feb 20, 2026

Sell Signal: Is CRISPR Therapeutics AG backed by strong institutional buyingGold Moves & Growth Focused Entry Point Reports - baoquankhu1.vn

Feb 20, 2026

Feb 18, 2026

Insider Stock Purchases: February 18, 2026 - Quiver Quantitative

Feb 18, 2026

Feb 18, 2026

Kalaris Therapeutics Insider Bought Shares Worth $5,000,006, According to a Recent SEC Filing - marketscreener.com

Feb 18, 2026

Feb 17, 2026

Kalaris Therapeutics (NASDAQ:KLRS) Director Acquires $5,000,005.74 in Stock - MarketBeat

Feb 17, 2026

Feb 17, 2026

Kalaris Therapeutics: Samsara Opportunity fund buys $5m in shares By Investing.com - Investing.com South Africa

Feb 17, 2026

Feb 17, 2026

Kalaris Therapeutics: Samsara Opportunity fund buys $5m in shares - Investing.com Australia

Feb 17, 2026

Feb 17, 2026

Akkaraju group reports 56.5% Kalaris (KLRS) ownership stake - Stock Titan

Feb 17, 2026

Feb 17, 2026

RTW discloses 5.7% Kalaris Therapeutics (KLRS) ownership stake - Stock Titan

Feb 17, 2026

Feb 14, 2026

Earnings Miss: How Kalaris Therapeutics Inc. stock compares to industry benchmarksJuly 2025 Action & Weekly Market Pulse Alerts - mfd.ru

Feb 14, 2026

Feb 12, 2026

Is Kalaris Therapeutics Inc. undervalued by DCF analysisSwing Trade & Capital Efficiency Focused Ideas - mfd.ru

Feb 12, 2026

Feb 11, 2026

Will Kalaris Therapeutics Inc. benefit from rate cutsJuly 2025 News Drivers & Fast Gain Stock Tips - mfd.ru

Feb 11, 2026

Feb 11, 2026

Kalaris Therapeutics Inc. (NASDAQ:KLRS) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

Feb 11, 2026

Feb 11, 2026

Kalaris Therapeutics Inc. (NASDAQ:KLRS) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Feb 11, 2026

Feb 11, 2026

Why Kalaris Therapeutics Inc. stock is trending among retail tradersQuarterly Investment Review & High Return Trade Opportunity Guides - mfd.ru

Feb 11, 2026

Feb 10, 2026

Kalaris Therapeutics Emerges with Focused Retinal Disease Strategy - AD HOC NEWS

Feb 10, 2026

Feb 09, 2026

Institution Moves: Whats the profit margin of Kalaris Therapeutics IncTrade Exit Report & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn

Feb 09, 2026

Jan 31, 2026

Short Interest in Kalaris Therapeutics Inc. (NASDAQ:KLRS) Increases By 60.8% - MarketBeat

Jan 31, 2026

Jan 31, 2026

Kalaris Therapeutics (NASDAQ:KLRS) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat

Jan 31, 2026

Jan 29, 2026

Smart Money: Should I add Kalaris Therapeutics Inc stock to my portfolioJuly 2025 Big Picture & Real-Time Buy Signal Notifications - baoquankhu1.vn

Jan 29, 2026

Jan 29, 2026

Kalaris to present phase 1 data of novel eye therapy at Macula Society - Investing.com Australia

Jan 29, 2026

Jan 28, 2026

Kalaris to Present Phase 1 Clinical Data for TH103 at the Macula Society Annual Meeting - Investing News Network

Jan 28, 2026

Jan 24, 2026

Kalaris Therapeutics (NASDAQ:KLRS) Rating Lowered to Sell at Wall Street Zen - MarketBeat

Jan 24, 2026

Jan 21, 2026

Kalaris Therapeutics raises $50M privately - MSN

Jan 21, 2026

Jan 20, 2026

What’s the MACD signal for Kalaris Therapeutics Inc.Double Top/Bottom Patterns & High Return Capital Strategies - bollywoodhelpline.com

Jan 20, 2026

Jan 17, 2026

Kalaris Therapeutics Inc. (NASDAQ:KLRS) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Jan 17, 2026

Jan 14, 2026

Buyback Watch: Will Kalaris Therapeutics Inc outperform small cap indexesJuly 2025 Recap & Fast Moving Stock Trade Plans - baoquankhu1.vn

Jan 14, 2026

Jan 14, 2026

Block Trades: Can Kalaris Therapeutics Inc weather a recessionWeekly Earnings Recap & Real-Time Price Movement Reports - baoquankhu1.vn

Jan 14, 2026

Jan 13, 2026

Swing Trade: Is Kalaris Therapeutics Inc. affected by consumer sentimentInsider Buying & AI Forecasted Stock Moves - baoquankhu1.vn

Jan 13, 2026

Jan 12, 2026

Support Test: What is Kalaris Therapeutics Incs 5 year growth outlookRecession Risk & AI Powered Market Entry Ideas - baoquankhu1.vn

Jan 12, 2026

Jan 09, 2026

How Kalaris Therapeutics Inc. stock responds to policy changesMarket Sentiment Report & Technical Pattern Based Buy Signals - Улправда

Jan 09, 2026

Jan 08, 2026

Why retail investors pile into Kalaris Therapeutics Inc. stockJuly 2025 Trade Ideas & Long-Term Investment Growth Plans - Улправда

Jan 08, 2026

Jan 08, 2026

Is Kalaris Therapeutics Inc. stock a defensive play in 2025Treasury Yields & Reliable Volume Spike Trade Alerts - Улправда

Jan 08, 2026

Dec 31, 2025

Short Interest in Kalaris Therapeutics Inc. (NASDAQ:KLRS) Expands By 26.1% - MarketBeat

Dec 31, 2025

Dec 26, 2025

Analysts’ Weekly Ratings Updates for Kalaris Therapeutics (KLRS) - Defense World

Dec 26, 2025

Dec 25, 2025

Chardan Capital Initiates Coverage on Kalaris Therapeutics (NASDAQ:KLRS) - Defense World

Dec 25, 2025

Dec 24, 2025

Kalaris Therapeutics announces initial data from TH103 trial - MSN

Dec 24, 2025

Dec 24, 2025

Chardan Capital Upgrades Kalaris Therapeutics (NASDAQ:KLRS) to Strong-Buy - MarketBeat

Dec 24, 2025

Dec 23, 2025

Chardan Capital Initiates Coverage of Kalaris Therapeutics (KLRS) with Buy Recommendation - Nasdaq

Dec 23, 2025

Dec 23, 2025

Chardan Initiates Kalaris Therapeutics at Buy With $19 Price Target - marketscreener.com

Dec 23, 2025